Delivering new insights to drive personalized trials

Nephrologie

Collaborate with a board-certified nephrologist (who is also in academia), to ensure successful trial design and execution

Engage Fortrea’s regulatory strategy and operational experts for data-driven planning

Leverage relationships with nephrology sites and trial stakeholders (such as Dialysis Organizations and Kidney Patient Advocacy Groups) to deliver timely diversity-focused recruitment

Experience matters when choosing a partner

Unser Partner werden

Die vergangenen 5 Jahre

178

Nephrology Studies

5,000+

Standorte

23,000+

Patienten

Häufigste Indikationen

Dialysis and End Stage Kidney Disease (ESKD)
Glomerular Disease
Chronic Kidney Disease (CKD) and its complications
Pediatric CDK and ESKD
Renal Impairment Studies

Erfahren Sie die aktuellsten Neuigkeiten von Fortrea

We’re sharing our latest news, events, and publications

ARTICLE

Going beyond the boundaries of a clinical trial

Artikel lesen

Webinar

Watch our renal/hepatic impairment webinar

Watch here

Artikel

Recent advances in the use of surrogate endpoints in kidney diseases

Artikel lesen

Webinar

Dr. Barbara Gillespie co-moderates the Kidney Health Initiative webinar (58 minutes)

View the recording

Why choose Fortrea for your next Nephrology trial?

Hear and apply our lessons learned across the different types of nephrology studies to understand the nuances of sites and recipe for successful trial execution in dialysis vs. rare kidney disease (e.g., Glomerular Disease) vs. common CKD (e.g., Diabetic Kidney Disease) patients
Benefit from our focused training specific to the needs of each type of nephrology study to address issues such as proper 24-hour urine collections, renal biomarker development, PRO collection and central lab monitoring
Harness the dedicated and overlapping expertise of our partners in Clinical Pharmacology Solutions and our Rare and Pediatric Disease colleagues

Renal Impairment Studies Seltene Krankheiten

Lernen Sie uns kennen

Das Team kennenlernen

Dr. Barbara S. Gillespie, MMS, FASN

Vice President & Therapeutic Strategy Leader
Biografie ansehen

Your agile partner for comprehensive nephrology clinical trials

We bring extensive depth of expertise to nephrology therapeutic development. Once your trial is underway, you can rely on Fortrea's clinical trial management team to provide close communication and collaboration. We use a highly flexible clinical platform for electronic patient-reported outcomes to provide high-quality data that enables you to stay connected to the progress of your program.

Als Anbieter eines umfassenden Managements klinischer Studien der Phasen I bis IV, klinischer Pharmakologie, von Lösungen für den Patientenzugang und anderer grundlegender Dienstleistungen arbeitet Fortrea mit aufstrebenden und großen Biopharma-, Medizintechnik- und Diagnostikunternehmen zur Förderung von Innovationen im Gesundheitswesen weltweit zusammen.